These results, together with previous evidence showing an mTOR-dependent impairment in invasion capabilities of GBM cells [122], suggest that the effects of mTOR inhibition can be further exploited to counteract glioma proliferation, migration, and invasion. This evidence concerns the gene MTOR and central nervous system cancer.